Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection

Background/Aims: Carnitine palmitoyltransferase 1A (CPT1A) is a rate-limiting enzyme in the transport of long-chain fatty acids for β-oxidation. Increasing evidence has indicated that CPT1A plays an important role in carcinogenesis. However, the expression and prognostic value of CPT1A in hepatocell...

Full description

Bibliographic Details
Main Authors: Shengsen Chen, Chao Wang, An Cui, Kangkang Yu, Chong Huang, Mengqi Zhu, Mingquan Chen
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-07-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/491779
_version_ 1811326816820920320
author Shengsen Chen
Chao Wang
An Cui
Kangkang Yu
Chong Huang
Mengqi Zhu
Mingquan Chen
author_facet Shengsen Chen
Chao Wang
An Cui
Kangkang Yu
Chong Huang
Mengqi Zhu
Mingquan Chen
author_sort Shengsen Chen
collection DOAJ
description Background/Aims: Carnitine palmitoyltransferase 1A (CPT1A) is a rate-limiting enzyme in the transport of long-chain fatty acids for β-oxidation. Increasing evidence has indicated that CPT1A plays an important role in carcinogenesis. However, the expression and prognostic value of CPT1A in hepatocellular carcinoma (HCC) have not been extensively studied. Methods: Here, we collected 66 post-operative liver cancer tissue samples. Gene profile expression was tested by RT-PCR. Receiver operating characteristic (ROC) analysis was performed and multivariate analysis with Cox’s Proportional Hazard Model was used for confirming the selected markers’ predictive efficiency for HCC patients’ survival. A simple risk scoring system was created based on Cox’s regression modeling and bootstrap internal validation. Results: Cox multivariate regression analysis demonstrated that CPT1A, tumor size, intrahepatic metastasis, TNM stage and histological grade were independent risk factors for the prognosis of HCC patients after surgery. Our genetic and clinical data-based (GC) risk scoring system revealed that HCC patients whose total score≥3 are more likely to relapse and die than patients whose total score < 3. Finally, the good discriminatory power of our risk scoring model was validated by bootstrap internal validation. Conclusions: The genetic and clinical data-based risk scoring model can be a promising predictive tool for liver cancer patients’ prognosis after operation.
first_indexed 2024-04-13T14:56:04Z
format Article
id doaj.art-4d8bf5a46c1a4ffc9f774a2073178771
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-04-13T14:56:04Z
publishDate 2018-07-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-4d8bf5a46c1a4ffc9f774a20731787712022-12-22T02:42:26ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-07-0148249150210.1159/000491779491779Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor ResectionShengsen ChenChao WangAn CuiKangkang YuChong HuangMengqi ZhuMingquan ChenBackground/Aims: Carnitine palmitoyltransferase 1A (CPT1A) is a rate-limiting enzyme in the transport of long-chain fatty acids for β-oxidation. Increasing evidence has indicated that CPT1A plays an important role in carcinogenesis. However, the expression and prognostic value of CPT1A in hepatocellular carcinoma (HCC) have not been extensively studied. Methods: Here, we collected 66 post-operative liver cancer tissue samples. Gene profile expression was tested by RT-PCR. Receiver operating characteristic (ROC) analysis was performed and multivariate analysis with Cox’s Proportional Hazard Model was used for confirming the selected markers’ predictive efficiency for HCC patients’ survival. A simple risk scoring system was created based on Cox’s regression modeling and bootstrap internal validation. Results: Cox multivariate regression analysis demonstrated that CPT1A, tumor size, intrahepatic metastasis, TNM stage and histological grade were independent risk factors for the prognosis of HCC patients after surgery. Our genetic and clinical data-based (GC) risk scoring system revealed that HCC patients whose total score≥3 are more likely to relapse and die than patients whose total score < 3. Finally, the good discriminatory power of our risk scoring model was validated by bootstrap internal validation. Conclusions: The genetic and clinical data-based risk scoring model can be a promising predictive tool for liver cancer patients’ prognosis after operation.https://www.karger.com/Article/FullText/491779Cpt1aPPARΑHepatocellular carcinomaRisk scoring systemPrognosis
spellingShingle Shengsen Chen
Chao Wang
An Cui
Kangkang Yu
Chong Huang
Mengqi Zhu
Mingquan Chen
Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection
Cellular Physiology and Biochemistry
Cpt1a
PPARΑ
Hepatocellular carcinoma
Risk scoring system
Prognosis
title Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection
title_full Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection
title_fullStr Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection
title_full_unstemmed Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection
title_short Development of a Genetic and Clinical Data-Based (GC) Risk Score for Predicting Survival of Hepatocellular Carcinoma Patients After Tumor Resection
title_sort development of a genetic and clinical data based gc risk score for predicting survival of hepatocellular carcinoma patients after tumor resection
topic Cpt1a
PPARΑ
Hepatocellular carcinoma
Risk scoring system
Prognosis
url https://www.karger.com/Article/FullText/491779
work_keys_str_mv AT shengsenchen developmentofageneticandclinicaldatabasedgcriskscoreforpredictingsurvivalofhepatocellularcarcinomapatientsaftertumorresection
AT chaowang developmentofageneticandclinicaldatabasedgcriskscoreforpredictingsurvivalofhepatocellularcarcinomapatientsaftertumorresection
AT ancui developmentofageneticandclinicaldatabasedgcriskscoreforpredictingsurvivalofhepatocellularcarcinomapatientsaftertumorresection
AT kangkangyu developmentofageneticandclinicaldatabasedgcriskscoreforpredictingsurvivalofhepatocellularcarcinomapatientsaftertumorresection
AT chonghuang developmentofageneticandclinicaldatabasedgcriskscoreforpredictingsurvivalofhepatocellularcarcinomapatientsaftertumorresection
AT mengqizhu developmentofageneticandclinicaldatabasedgcriskscoreforpredictingsurvivalofhepatocellularcarcinomapatientsaftertumorresection
AT mingquanchen developmentofageneticandclinicaldatabasedgcriskscoreforpredictingsurvivalofhepatocellularcarcinomapatientsaftertumorresection